Light Therapy to Increase Energy in Adolescents and Young Adults Newly Diagnosed With Solid Tumors: A Pilot Study

St. Jude Children's Research Hospital

Status

Completed

Conditions

Neoplasms

Fatigue

Treatments

Other: Dim Red Light

Other: Bright White Light

Study type

Interventional

Funder types

Other

Identifiers

NCT02429063

LITE

NCI-2015-00679 (Registry Identifier)

Details and patient eligibility

About

Fatigue is one of the most consistent and distressing symptoms reported by pediatric oncology patients. The investigators' work has demonstrated that in the period from diagnosis through the initial 8 weeks of treatment, adolescents and young adults with solid tumors experience substantial fatigue that is not related to sleep disruption. Fatigue can contribute to many adverse outcomes including poor treatment adherence, reduced social activities, depressive symptoms, behavior problems, and poorer quality of life. Unfortunately, no definitive intervention to reduce fatigue has been developed for pediatric oncology patients. Investigators propose a study to estimate the feasibility and acceptability of bright light therapy as an intervention to decrease fatigue in adolescents and young adults who are newly diagnosed and receiving treatment for solid tumors, including lymphoma.

Full description

This feasibility and acceptability study will assess the rate of consent to, adherence to, and side effects from a therapy study in a randomized trial comparing bright white light (BWL) to dim red light (DRL). Four questionnaires will be distributed to patients and/or their parents, depending upon the questionnaire, to study the fatigue, quality of life, mood symptoms, and side effects of the BWL/DRL intervention in adolescents and young adults being treated for solid tumors, including lymphoma.

PRIMARY OBJECTIVES:

To estimate the feasibility and acceptability of a BWL intervention compared to a DRL standard comparison group in adolescent/young adult solid tumor and lymphoma patients.

SECONDARY OBJECTIVE:

To estimate the effect size of this intervention on measures of fatigue in order to design a larger clinical trial of efficacy of a randomized control trial of BWL versus DRL intervention for fatigue in pediatric oncology patients.

OTHER PRESPECIFIED OBJECTIVES:

Estimate the effect of participant location (inpatient, hospital-based housing, or home) on adherence.
Estimate rates of depressive symptoms.
Describe quality of life.

Enrollment

55 patients

Sex

All

Ages

12+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Age 12 years or older
Has initiated treatment as part of an active St. Jude Children's Research Hospital (SJCRH) treatment plan
≤ 30 days post diagnosis of a solid tumor or lymphoma
Patient speaks, reads and writes in English or Spanish
Potential participant/guardian is willing to sign informed consent

Exclusion criteria

Blind or having a history of eye disease including, but not limited to, macular degeneration, or other diagnosed retinal problems
Undergone laser corrective eye surgery in the past 30 days
Significant physiological or psychological impairment that interferes with participation (e.g., migraines, bipolar disorder, psychosis, seasonal affective disorder)
Recently started on anti-depressant medications (past one month for those on Selective Serotonin Reuptake Inhibitors [SSRI] and past two months for those started on Monoamine Oxidase Inhibitors [MAOI])